Growth Metrics

Quest Diagnostics (DGX) Return on Equity (2017 - 2025)

Quest Diagnostics (DGX) has disclosed Return on Equity for 16 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 1.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.14% for FY2025, 1.0% up from the prior year.
  • Return on Equity hit 0.14% in Q4 2025 for Quest Diagnostics, up from 0.14% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.33% in Q4 2021 to a low of 0.07% in Q1 2021.
  • Historically, Return on Equity has averaged 0.17% across 5 years, with a median of 0.14% in 2023.
  • Biggest YoY gain for Return on Equity was 24bps in 2022; the steepest drop was -17bps in 2022.
  • Year by year, Return on Equity stood at 0.33% in 2021, then crashed by -52bps to 0.16% in 2022, then decreased by -13bps to 0.14% in 2023, then decreased by -4bps to 0.13% in 2024, then rose by 5bps to 0.14% in 2025.
  • Business Quant data shows Return on Equity for DGX at 0.14% in Q4 2025, 0.14% in Q3 2025, and 0.14% in Q2 2025.